High PD-1/PD-L1 checkpoint interaction infers tumor selection and therapeutic sensitivity to anti-PD-1/PD-L1 treatment

1. Sanchez-Magraner, L.
2. Miles, J.
3. Baker, C.L.
4. Applebee, C.J.
5. Lee, D.-J.
6. Elsheikh, S.
7. Lashin, S.
8. Withers, K.
9. Watts, A.G.
10. Parry, R.
11. Edmead, C.
12. Lopez, J.I.
13. Mehta, R.
14. Italiano, A.
15. Ward, S.G.
16. Parker, P.J.
17. Larijani, B.